Findlay Park Partners LLP trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 6.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,107,151 shares of the medical research company’s stock after selling 150,000 shares during the period. Thermo Fisher Scientific comprises approximately 3.9% of Findlay Park Partners LLP’s portfolio, making the stock its 4th biggest holding. Findlay Park Partners LLP owned about 0.53% of Thermo Fisher Scientific worth $398,673,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Amalgamated Bank raised its holdings in shares of Thermo Fisher Scientific by 57.0% during the second quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock worth $7,837,000 after acquiring an additional 16,308 shares in the last quarter. Mutual of America Capital Management LLC raised its holdings in shares of Thermo Fisher Scientific by 2.1% during the second quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock worth $8,327,000 after acquiring an additional 977 shares in the last quarter. Mitchell Capital Management Co. raised its holdings in shares of Thermo Fisher Scientific by 40.3% during the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock worth $7,841,000 after acquiring an additional 12,910 shares in the last quarter. State Board of Administration of Florida Retirement System raised its holdings in shares of Thermo Fisher Scientific by 0.9% during the second quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock worth $101,317,000 after acquiring an additional 5,213 shares in the last quarter. Finally, San Francisco Sentry Investment Group CA purchased a new stake in shares of Thermo Fisher Scientific during the second quarter worth $1,451,000. Institutional investors and hedge funds own 86.16% of the company’s stock.

Several brokerages recently issued reports on TMO. Leerink Swann reiterated an “outperform” rating and set a $200.00 price objective (down from $216.00) on shares of Thermo Fisher Scientific in a report on Monday, December 4th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 target price on the stock in a research report on Tuesday, October 31st. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. Jefferies Group reissued a “hold” rating and set a $195.00 target price on shares of Thermo Fisher Scientific in a research report on Thursday, September 28th. Finally, Goldman Sachs Group initiated coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus target price of $205.21.

In other news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc. (NYSE:TMO) traded up $2.33 during trading on Friday, reaching $187.96. 2,429,212 shares of the company’s stock traded hands, compared to its average volume of 1,666,042. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. The firm has a market capitalization of $75,371.02, a P/E ratio of 20.65, a price-to-earnings-growth ratio of 1.72 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 52-week low of $139.88 and a 52-week high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm’s revenue was up 13.9% compared to the same quarter last year. During the same period last year, the business posted $2.03 earnings per share. equities research analysts forecast that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

TRADEMARK VIOLATION WARNING: This report was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/12/10/findlay-park-partners-llp-sells-150000-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.